Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.
暂无分享，去创建一个
B. Pégourié | P. Moreau | F. Magrangeas | S. Minvielle | H. Avet-Loiseau | M. Macro | G. Marit | C. Mathiot | T. Facon | D. Bouscary | M. Attal | L. Campion | A. Stoppa | M. Tiab | E. Voog | M. Wetterwald | C. Hulin | D. Caillot | A. Banos | L. Voillat | J. Jaubert | C. Traullé | B. Kolb